Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Director/PDMR Shareholding

24 Sep 2019 11:37

RNS Number : 4784N
Falanx Group Limited
24 September 2019
Β 

24 September 2019

Β 

FALANX GROUP LIMITED

(the "Company")

Β 

PDMR dealing

Β 

Falanx Group Limited (AIM: FLX), the global cyber security and intelligence services provider, announces that Mike Read, CEO, has today acquired 400,000 ordinary shares in the Company at 1.789 pence per share.

Β 

Following this acquisition, Mike Read is now interested in 11,053,940 ordinary shares in the Company representing 2.76% of the current issued share capital.

Β 

Enquiries:

Β 

Falanx Group Limited

Alex Hambro Chairman

Mike Read CEO

Ian Selby CFO

Β 

Via IFC

Stifel Nicolaus Europe Limited, Nomad and Joint Broker

Fred Walsh / Alex Price / Neil Shah

Β 

+ 44 (0) 207 710 7600

Turner Pope International Limited, Joint Broker

James Pope / Ben Turner

Β 

+44 (0) 203 621 4120

Β 

IFC Advisory Ltd

Financial PR & IR

Graham Herring / Miles Nolan / Zach Cohen

+44 (0) 203 934 663

Β 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. For more information: http://www.falanx.com/

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

Β Β 1

Β 

Details of the person discharging managerial responsibilities / person closely associatedΒ 

a)

Β 

NamesΒ 

Michael David Read

2

Β 

Reason for the notification

a)

Β 

Position/status

Β 

CEO

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitorΒ 

a)

Β 

Name

Β 

Falanx Group Limited

b)

Β 

LEI

Β 213800YO4F9CUQLALV19

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Ordinary Shares of nil par value

b)

Identification codeΒ 

Β 

VGG3338A1075

c)

Β 

Nature of the transactionΒ 

Β 

Purchase of Ordinary Shares

d)

Β 

Price(s) and volume(s)

Volume(s):

400,000 Ordinary Shares

Price: 1.789 pence per Ordinary Share

d)

Β 

Aggregated informationΒ 

- Aggregated volume

- Price

N/A

Β 

e)

Β 

Date of the transactionsΒ 

24 September 2019

f)

Β 

Place of the transaction

London Stock Exchange

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHBGGDCUXDBGCS
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.